Rio de Janeiro, Brazil

Eliezer J De Barreiro


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eliezer J De Barreiro: Innovator in Cardiac Treatment

Introduction

Eliezer J De Barreiro is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic properties. His work focuses on addressing critical health issues such as congestive heart failure and muscle fatigue.

Latest Patents

Eliezer J De Barreiro holds a patent for a compound known as Thienylhydrazon, which exhibits digitalis-like properties. This invention discloses a compound with a specific formula, wherein R is selected from a group consisting of hydrogen, alkyl of 1 to 6 carbon atoms, unsubstituted phenyl, and substituted phenyl. The compound also includes pharmaceutically acceptable salts that demonstrate positive inotropic effects on cardiac and skeletal muscle. The invention further details a novel method for synthesizing 3,4-methylenedioxybenzoyl-2-thienylhydrazone, also known as LASSBio-294. This compound is particularly useful for treating congestive heart failure and muscle fatigue, while lacking the toxic effects commonly associated with digitalis glycosides.

Career Highlights

Eliezer J De Barreiro is affiliated with the University System of Maryland, where he continues to engage in research and development. His innovative work has the potential to improve treatment options for patients suffering from heart conditions and related ailments.

Collaborations

Throughout his career, Eliezer has collaborated with esteemed colleagues such as Roberto Takashi Sudo and Edson X Albuquerque. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Eliezer J De Barreiro is a prominent figure in the field of pharmaceutical innovation, with a focus on developing effective treatments for cardiac issues. His contributions, particularly through his patent on Thienylhydrazon, highlight the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…